Abstract:Sympathetic activation plays a critical role in the development of hypertension and cardiovascular disease, including heart failure and arrhythmias. Renal nerves contribute to the regulation of blood pressure and fluid volume through renal sympathetic efferent nerves, and to the modulation of sympathetic outflow through renal sensory afferent nerves. Previous studies including ours suggest that selective afferent renal denervation with preservation of efferent renal nerves can significantly decrease central sympathetic outflow in animal models of hypertension with renal damage. In Dahl salt-sensitive rats fed high salt diet from an early age, a model of hypertensive heart failure, this central sympathoinhibition by afferent renal denervation may attenuate the development of heart failure without significant blood pressure reduction. Accumulating clinical evidence supports the efficacy of renal denervation as an antihypertensive treatment. However, it remains important to clarify the appropriate indications and predictors of responders to renal denervation in the treatment of hypertension. Several clinical studies suggest beneficial effects of renal denervation in patients with heart disease, with or without hypertension, although most were not sham-controlled. In particular, some clinical studies have demonstrated that renal denervation reduces the incidence of atrial fibrillation or cardiovascular events even without a significant antihypertensive effect. It is essential to accumulate more insightful data in patients undergoing renal denervation, to establish the efficacy of renal denervation in patients with cardiovascular disease in the clinical setting, and to elucidate the therapeutic mechanisms of renal denervation and the renal nerves-linked pathophysiology of cardiovascular disease in basic research. This review outlines the effects of renal denervation on sympathetic activity and organ damage in animal models of hypertension and hypertensive heart failure, including our own data. Beyond the antihypertensive effects, the beneficial effects of renal denervation on cardiovascular disease are also discussed based on clinical studies. Several animal and clinical studies suggest the cardioprotective effects of renal denervation even in the absence of significant blood pressure reduction, probably due to its sympathoinhibitory effects.

Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases

Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings

Autonomic Modulation for Cardiovascular Disease

Present Evidence of Determinants to Predict the Efficacy of Renal Denervation

Advances in the therapy of sympathetic denervation in congestive heart failure

Novel Strategies and Underlying Protective Mechanisms of Modulation of Vagal Activity in Cardiovascular Diseases

Non-invasive Autonomic Neuromodulation Is Opening New Landscapes for Cardiovascular Diseases

Hypertension and Device-Based Therapies for Resistant Hypertension: An Up-to-Date Review

Progress of catheter-based renal sympathetic denervation in the treatment of resistant hypertension and other related diseases

Device-based neuromodulation for cardiovascular diseases and patient' s age

The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease

Renal denervation: a key approach to hypertension and cardiovascular disease

Autonomic Modulation by Electrical Stimulation of the Parasympathetic Nervous System: An Emerging Intervention for Cardiovascular Diseases

Modulation of renal sympathetic innervation: recent insights beyond blood pressure control

Renal Sympathetic Denervation - A Review of Applications in Current Practice

Advances in Renal Sympathetic Denervation

Vagal Nerve Modulation: A Promising New Therapeutic Approach for Cardiovascular Diseases

Clinical Benefits of Renal Denervation Besides Blood Pressure Reduction

Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives

Efficacy And Safety Of Catheter-Based Renal Sympathetic Denervation In Treatment Of Chronic Heart Failure

Pharmacological Modulation of Vagal Nerve Activity in Cardiovascular Diseases